Maternal dietary DHA supplementation to improve inflammatory outcomes in the preterm infant

Advances in Nutrition

Volumn 3, Issue 3, 2012, Pages 370-376

  Valentine, Christina J ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; ESSENTIAL FATTY ACID; LINOLENIC ACID;

ARTICLE; BREAST MILK; CHEMISTRY; CLINICAL TRIAL (TOPIC); DIET SUPPLEMENTATION; FEMALE; HUMAN; INFANT; INFLAMMATION; LIVER; MATERNAL NUTRITION; METABOLISM; NEWBORN; NUTRITIONAL REQUIREMENT; PATHOPHYSIOLOGY; PREMATURITY;

ALPHA-LINOLENIC ACID; CLINICAL TRIALS AS TOPIC; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; FATTY ACIDS, ESSENTIAL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INFLAMMATION; LIVER; MATERNAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; MILK, HUMAN; NUTRITIONAL REQUIREMENTS;

EID: 84866780920     PISSN: 21618313     EISSN: 21565376     Source Type: Journal    
DOI: 10.3945/an.111.001248     Document Type: Conference Paper

References (90)

1. Innis SM. Essential fatty acid transfer and fetal development. Placenta. 2005;(26 Suppl Ap):S70-75.
2. Lapillonne A, Jensen CL. Reevaluation of the DHA requirement for the premature infant. Prostaglandins Leukot Essent Fatty Acids. 2009;81:143-50.
3. Montgomery C, Speake BK, Cameron A, Sattar N, Weaver LT. Maternal docosahexaenoic acid supplementation and fetal accretion. Br J Nutr. 2003;90:135-45.
4. IUPAC-IUB Commission on Biochemical Nomenclature. The nomenclature of lipids (recommendations 1976). IUPAC-IUB Commission on Biochemical Nomenclature. J Lipid Res. 1978;19:114-28.
5. Engelmann B, Wiedmann MK. Cellular phospholipid uptake:Flexible paths to coregulate the functions of intracellular lipids. Biochim Biophys Acta. 2010;1801:609-16.
6. Brenna JT, Lapillonne A. Background paper on fat and fatty acid requirements during pregnancy and lactation. Ann Nutr Metab. 2009;55:97-122.
7. Hong S, Lu Y, Yang R, Gotlinger KH, Petasis NA, Serhan CN. Resolvin D1, protectin D1, and related docosahexaenoic acid-derived products: analysis via electrospray/low energy tandem mass spectrometry based on spectra and fragmentation mechanisms. J Am Soc Mass Spectrom. 2007;18:128-44.
8. Querques G, Forte R, Souied EH. Retina and omega-3. J Nutr Metab. 2011;2011:748361.
9. Jeffrey BG, Weisinger HS, Neuringer M, Mitchell DC. The role of docosahexaenoic acid in retinal function. Lipids. 2001;36:859-71.
10. Blasbalg TL, Hibbeln JR, Ramsden CE, Majchrzak SF, Rawlings RR. Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century. Am J Clin Nutr. 2011;93:950-62.
11. German JB, Dillard CJ. Composition, structure and absorption of milk lipids:a source of energy, fat-soluble nutrients and bioactive molecules. Crit Rev Food Sci Nutr. 2006;46:57-92.
12. German JB. Dietary lipids from an evolutionary perspective:sources, structures and functions. Matern Child Nutr. 2011;7(Suppl 2):2-16.
13. Clandinin MT, Chappell JE, Heim T, Swyer PR, Chance GW. Fatty acid utilization in perinatal de novo synthesis of tissues. Early Hum Dev. 1981;5:355-66.
14. Carnielli VP, Simonato M, Verlato G, Luijendijk I, De Curtis M, Sauer PJ, Cogo PE. Synthesis of long-chain polyunsaturated fatty acids in preterm newborns fed formula with long-chain polyunsaturated fatty acids. Am J Clin Nutr. 2007;86:1323-30.
15. Innis SM. Perinatal biochemistry and physiology of long-chain polyunsaturated fatty acids. J Pediatr. 2003;143(4 Suppl)S1-8.
16. Uauy R, Mena P, Wegher B, Nieto S, Salem N Jr. Long chain polyunsaturated fatty acid formation in neonates:effect of gestational age and intrauterine growth. Pediatr Res. 2000;47:127-35.
17. Souci SW, Fachmann W, Kraut H. Food composition and nutrition tables. Med Pharm. 2008.
18. Institute of Medicine of the National Academies. Dietary reference intakes (DRIs):for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids. Washington, DC:National Academies Press; 2005.
19. Jensen CL, Maude M, Anderson RE, Heird WC. Effect of docosahexaenoic acid supplementation of lactating women on the fatty acid composition of breastmilk lipids and maternal and infant plasma phospholipids. Am J Clin Nutr. 2000; 71(1, Suppl)292S-9S.
20. Koletzko B, Cetin I, Brenna JT. Dietary fat intakes for pregnant and lactating women. Br J Nutr. 2007;98:873-7.
21. Agostoni C, Buonocore G, Carnielli VP, De Curtis M, Darmaun D, Decsi T, Domellof M, Embleton ND, Fusch C, Genzel-Boroviczeny O, et al. Enteral nutrient supply for preterm infants:commentary from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition Committee on Nutrition. J Pediatr Gastroenterol Nutr. 2010;50:85-91.
22. Bitman J,Wood DL, Mehta NR, Hamosh P, Hamosh M. Comparison of the cholesteryl ester composition of human milk from preterm and term mothers. J Pediatr Gastroenterol Nutr. 1986;5:780-6.
23. Picciano MF. Nutrient composition of human milk. Pediatr Clin North Am. 2001;48:53-67.
24. Kuratko CN, Salem N Jr. Biomarkers of DHA status. Prostaglandins Leukot Essent Fatty Acids. 2009;81:111-8.
25. Gil A, Ramirez M, Gil M. Role of long-chain polyunsaturated fatty acids in infant nutrition. Eur J Clin Nutr. 2003;57(Suppl 1):S31-4.
26. Friedman Z. Essential fatty acids revisited. Am J Dis Child. 1980;134: 397-408.
27. Friedman Z, Danon A, Stahlman MT, Oates JA. Rapid onset of essential fatty acid deficiency in the newborn. Pediatrics. 1976;58:640-9.
28. Hansen AE, Wiese HF, Boelsche AN, Haggard ME, Adam DJD, Davis H. Role of linoleic acid in infant nutrition. Pediatrics. 1963;31:171-92.
29. Carlson SE. Docosahexaenoic acid supplementation in pregnancy and lactation. Am J Clin Nutr. 2009;89:678S-84S.
30. Valentine CJ, Puthoff TD. Enhancing parenteral nutrition therapy for the neonate. Nutr Clin Pract. 2007;22:183-93.
31. Gura KM, Duggan CP, Collier SB, Jennings RW, Folkman J, Bistrian BR, Puder M. Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil:implications for future management. Pediatrics. 2006;118:e197-201.
32. Mayes C, Burdge GC, Bingham A, Murphy JL, Tubman R, Wootton SA. Variation in [U-13C] alpha linolenic acid absorption, beta-oxidation and conversion to docosahexaenoic acid in the pre-term infant fed a DHA-enriched formula. Pediatr Res. 2006;59:271-5.
33. De Tomás ME, Mercuri O, Rodrigo A. Effects of dietary protein and EFA deficiency on liver delta 5, delta 6 and delta 9 desaturase activities in the early developing rat. J Nutr. 1980;110:595-9.
34. Brenner RR. Hormonal modulation of delta6 and delta5 desaturases: case of diabetes. Prostaglandins Leukot Essent Fatty Acids. 2003;68: 151-62.
35. Das UN. Can essential fatty acids reduce the burden of disease(s)? Lipids Health Dis. 2008;7:9.
36. Embleton NE, Pang N, Cooke RJ. Postnatal malnutrition and growth retardation:an inevitable consequence of current recommendations in preterm infants? Pediatrics. 2001;107:270-3.
37. Fernandez EF, Montman R, Watterberg KL. ACTH and cortisol response to critical illness in term and late preterm newborns. J Perinatol. 2008;28:797-802.
38. Slattery MM, Morrison JJ. Preterm delivery. Lancet. 2002;360:1489-97.
39. Lawrence RA, Lawrence R. Host-resistance factors and immunologic significance of human milk. In:Breastfeeding:a guide for the medical profession. St. Louis:Mosby; 2005. p. 976.
40. Hall MW, Gavrilin MA, Knatz NL, Duncan MD, Fernandez SA, Wewers MD. Monocyte mRNA phenotype and adverse outcomes from pediatric multiple organ dysfunction syndrome. Pediatr Res. 2007;62:597-603.
41. Vitale M, Della Chiesa M, Carlomagno S, Pende D, Arico M, Moretta L, Moretta A. NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor. Blood. 2005;106:566-71.
42. Lawrence T, Willoughby DA, Gilroy DW. Anti-inflammatory lipid mediators and insights into the resolution of inflammation. Nat Rev Immunol. 2002;2:787-95.
43. Maródi L. Innate cellular immune responses in newborns. Clin Immunol. 2006;118:137-44.
44. Clapp DW. Developmental regulation of the immune system. Semin Perinatol. 2006;30:69-72.
45. Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity:update on Toll-like receptors. Nat Immunol. 2010;11:373-84.
46. Levy O. Innate immunity of the human newborn:distinct cytokine responses to LPS and other Toll-like receptor agonists. J Endotoxin Res. 2005;11:113-6.
47. Rosen D, Lee JH, Cuttitta F, Rafiqi F, Degan S, Sunday ME. Accelerated thymic maturation and autoreactive T cells in bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2006;174:75-83.
48. Jobe AH, Ikegami M. Antenatal infection/inflammation and postnatal lung maturation and injury. Respir Res. 2001;2:27-32.
49. Ng PC, Li K, Wong RP, Chui K, Wong E, Li G, Fok TF. Proinflammatory and anti-inflammatory cytokine responses in preterm infants with systemic infections. Arch Dis Child Fetal Neonatal Ed. 2003;88:F209-13.
50. De Dooy JJ, Mahieu LM, Van Bever HP. The role of inflammation in the development of chronic lung disease in neonates. Eur J Pediatr. 2001;160:457-63.
51. Paananen R, Husa AK, Vuolteenaho R, Herva R, Kaukola T, Hallman M. Blood cytokines during the perinatal period in very preterm infants: relationship of inflammatory response and bronchopulmonary dysplasia. J Pediatr 2009;154:39-43.e33.
52. Leaphart CL, Cavallo J, Gribar SC, Cetin S, Li J, Branca MF, Dubowski TD, Sodhi CP, Hackam DJ. A critical role for TLR4 in the pathogenesis of necrotizing enterocolitis by modulating intestinal injury and repair. J Immunol. 2007;179:4808-20.
53. Liu Y, Zhu L, Fatheree NY, Liu X, Pacheco SE, Tatevian N, Rhoads JM. Changes in intestinal Toll-like receptors and cytokines precede histological injury in a rat model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol. 2009;297:G442-50.
54. Ghosh-Choudhury T, Mandal CC, Woodruff K, St Clair P, Fernandes G, Choudhury GG, Ghosh-Choudhury N. Fish oil targets PTEN to regulate NFkappaB for downregulation of anti-apoptotic genes in breast tumor growth. Breast Cancer Res Treat. 2009;118:213-28.
55. Cotogni P, Muzio G, Trombetta A, Ranieri VM, Canuto RA. Impact of the omega-3 to omega-6 polyunsaturated fatty acid ratio on cytokine release in human alveolar cells. JPEN J Parenter Enteral Nutr. 2011;35:114-21.
56. Fan J, Ye RD, Malik AB. Transcriptional mechanisms of acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2001;281:L1037-50.
57. Chao AC, Ziadeh BI, Diau GY, Wijendran V, Sarkadi-Nagy E, Hsieh AT, Nathanielsz PW, Brenna JT. Influence of dietary long-chain PUFA on premature baboon lung FA and dipalmitoyl PC composition. Lipids. 2003;38:425-9.
58. Rogers LK, Valentine CJ, Pennell M, Velten M, Britt RD, Dingess K, Zhao X, Welty SE, Tipple TE. Maternal docosahexaenoic acid supplementation decreases lung inflammation in hyperoxia-exposed newborn mice. J Nutr. 2011;141:214-22.
59. Lu J, Jilling T, Li D, Caplan MS. Polyunsaturated fatty acid supplementation alters proinflammatory gene expression and reduces the incidence of necrotizing enterocolitis in a neonatal rat model. Pediatr Res. 2007;61:427-32.
60. Caplan MS, Russell T, Xiao Y, Amer M, Kaup S, Jilling T. Effect of polyunsaturated fatty acid (PUFA) supplementation on intestinal inflammation and necrotizing enterocolitis (NEC) in a neonatal rat model. Pediatr Res. 2001;49:647-52.
61. Balvers MG, Verhoeckx KC, Plastina P, Wortelboer HM, Meijerink J, Witkamp RF. Docosahexaenoic acid and eicosapentaenoic acid are converted by 3T3-L1 adipocytes to N-acyl ethanolamines with antiinflammatory properties. Biochim Biophys Acta. 2010;1801:1107-14.
62. Yavin E, Glozman S, Green P. Docosahexaenoic acid accumulation in the prenatal brain:prooxidant and antioxidant features. J Mol Neurosci. 2001;16:229-35, discussion 279-84.
63. Schanler RJ, Lau C, Hurst NM, Smith EO. Randomized trial of donor human milk versus preterm formula as substitutes for mothers' own milk in the feeding of extremely premature infants. Pediatrics. 2005; 116:400-6.
64. Schanler RJ, Shulman RJ, Lau C, Smith EO, Heitkemper MM. Feeding strategies for premature infants:randomized trial of gastrointestinal priming and tube-feeding method. Pediatrics. 1999;103:434-9.
65. Sisk PM, Lovelady CA, Dillard RG, Gruber KJ, O'Shea TM. Early human milk feeding is associated with a lower risk of necrotizing enterocolitis in very low birth weight infants. J Perinatol. 2007;27: 428-33.
66. Sullivan S, Schanler RJ, Kim JH, Patel AL, Trawoger R, Kiechl-Kohlendorfer U, Chan GM, Blanco CL, Abrams S, Cotton CM, et al. An exclusively human milk-based diet is associated with a lower rate of necrotizing enterocolitis than a diet of human milk and bovine milk-based products. J Pediatr. 2010;156:562-7.e561.
67. Porcelli PJ, Weaver RG Jr. The influence of early postnatal nutrition on retinopathy of prematurity in extremely low birth weight infants. Early Hum Dev. 2010;86:391-6.
68. Boyd CA, Quigley MA, Brocklehurst P. Donor breast milk versus infant formula for preterm infants:systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2007;92:F169-75.
69. Lonnerdal B. Nutritional and physiologic significance of human milk proteins. Am J Clin Nutr. 2003;77:1537S-43S.
70. Arnold LD. Clinical uses of donor milk. J Hum Lact. 1990;6:132-3.
71. Valentine CJ, Morrow G, Fernandez S, Gulati P, Bartholomew D, Long D, Welty SE, Morrow AL, Rogers LK. Docosahexaenoic acid and amino acid contents in pasteurized donor milk are low for preterm infants. J Pediatr. 2010;157:906-10.
72. Shennan DB, Peaker M. Transport of milk constituents by the mammary gland. Physiol Rev. 2000;80:925-51.
73. Jensen RG. Lipids in human milk. Lipids. 1999;34:1243-71.
74. Brenna JT, Varamini B, Jensen RG, Diersen-Schade DA, Boettcher JA, Arterburn LM. Docosahexaenoic and arachidonic acid concentrations in human breast milk worldwide. Am J Clin Nutr. 2007;85:1457-64.
75. Fewtrell MS, Morley R, Abbott RA, Singhal A, Isaacs EB, Stephenson T, MacFadyen U, Lucas A. Double-blind, randomized trial of long-chain polyunsaturated fatty acid supplementation in formula fed to preterm infants. Pediatrics. 2002;110:73-82.
76. Innis SM, Adamkin DH, Hall RT, Kalhan SC, Lair C, Lim M, Stevens DC, Twist PF, Diersen-Schade DA, Harris CL, et al. Docosahexaenoic acid and arachidonic acid enhance growth with no adverse effects in preterm infants fed formula. J Pediatr. 2002;140:547-54.
77. Birch EE, Garfield S, Hoffman DR, Uauy R, Birch DG. A randomized controlled trial of early dietary supply of long-chain polyunsaturated fatty acids and mental development in term infants. Dev Med Child Neurol. 2000;42:174-81.
78. Hoffman DR, Birch EE, Castaneda YS, Fawcett SL, Wheaton DH, Birch DG, Uauy R. Visual function in breast-fed term infants weaned to formula with or without long-chain polyunsaturates at 4 to 6 months:a randomized clinical trial. J Pediatr. 2003;142:669-77.
79. Jensen CL, Voigt RG, Llorente AM, Peters SU, Prager TC, Zou YL, Rozelle JC, Turcich MR, Fraley JK, Anderson RE, et al. Effects of early maternal docosahexaenoic acid intake on neuropsychological status and visual acuity at five years of age of breast-fed term infants. J Pediatr. 2010;157:900-5.
80. Forsyth JS, Willatts P, Agostoni C, Bissenden J, Casaer P, Boehm G. Long chain polyunsaturated fatty acid supplementation in infant formula and blood pressure in later childhood:follow up of a randomised controlled trial. BMJ. 2003;326:953.
81. Lucas A. Programming by early nutrition:an experimental approach. J Nutr. 1998;128(2 Suppl)401S-6S.
82. Simmer K. Longchain polyunsaturated fatty acid supplementation in preterm infants. Cochrane Database Syst Rev. 2000;(2):CD000375.
83. Makrides M, Gibson RA, McPhee AJ, Yelland L, Quinlivan J, Ryan P. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children:a randomized controlled trial. JAMA. 2010;304:1675-83.
84. Henriksen C, Haugholt K, Lindgren M, Aurvag AK, Ronnestad A, Gronn M, Solberg R, Moen A, Nakstad B, Berge RK, et al. Improved cognitive development among preterm infants attributable to early supplementation of human milk with docosahexaenoic acid and arachidonic acid. Pediatrics. 2008;121:1137-45.
85. Martin CR, Dasilva DA, Cluette-Brown JE, Dimonda C, Hamill A, Bhutta AQ, Coronel E,Wilschanski M, Stephens AJ, Driscoll DF, et al. Decreased postnatal docosahexaenoic and arachidonic acid blood levels in premature infants are associated with neonatal morbidities. J Pediatr. 2011; 159:743-9.e741-2.
86. Makrides M, Neumann MA, Gibson RA. Effect of maternal docosahexaenoic acid (DHA) supplementation on breast milk composition. Eur J Clin Nutr. 1996;50:352-7.
87. Wijendran V, Hayes KC. Dietary n-6 and n-3 fatty acid balance and cardiovascular health. Annu Rev Nutr. 2004;24:597-615.
88. Klebanoff MA,HarperM, Lai Y, Thorp J Jr, Sorokin Y, VarnerMW,Wapner RJ, Caritis SN, Iams JD, Carpenter MW, et al. Fish consumption, erythrocyte fatty acids, and preterm birth. Obstet Gynecol. 2011;117:1071-7.
89. Salvig JD, Lamont RF. Evidence regarding an effect of marine n-3 fatty acids on preterm birth:a systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2011;90:825-38.
90. Ratnayake WM, Galli C. Fat and fatty acid terminology, methods of analysis and fat digestion and metabolism:a background review paper. Ann Nutr Metab, 2009;55:8-43.